Check out the latest panel discussion on https://t.co/PDNZqzNBxn and dive into a panel discussion around smouldering MS and effective communication strategies. #MSResearch#triMSonline
This content is supported by a partnership agreement with Sanofi and a sponsorship from Merck.
Content is now available for healthcare professionals! Insightful talks from Professor Giovannoni and Professor Scalfari, alongside a powerful perspective from Julia who lives with MS.
This content is supported by a partnership agreement with Sanofi and a sponsorship from Merck.
The new #triMSonline website is live for healthcare professionals! Register to view our initial content release on chronic neuroinflammation and smouldering-associated worsening (SAW). This content is supported by a partnership agreement with Sanofi and a sponsorship from Merck.
#triMSonline - Addressing chronic neuroinflammation: detecting, monitoring and communicating smouldering-associated-worsening (SAW)
Follow us for updates! This content is supported by a partnership agreement with Sanofi and a sponsorship from Merck.
New report Brain health – time matters in #MS, #NMOSD & #MOGAD launches 19 Sept 2024, 13:30–15:00 CET at @ECTRIMS, in #Copenhagen & virtually. Join @GavinGiovannoni, Helmut Butzkeuven, @AnneHelme, @NerdyNeuroMD & @TheSumairaFDN to learn about policy change. #BrainHealthTM#OHPF
On demand access to the seventh #triMSonline conference is still available!
Watch ‘BTK inhibitors: an exciting new era in MS therapy’ here: https://t.co/7Sus7rwlVn
Remember that you can revisit all content from the #triMSonline conference, including visiting our exhibition booths, by logging onto the conference platform.
Register for free here: https://t.co/7Sus7rwlVn
Have you watched the seventh #triMSonline conference?
We would love to hear your feedback! Please let us know your comments and suggestions by completing the evaluation form within the menu ribbon on the #triMSonline platform: https://t.co/7Sus7rwTKV
On-demand access for the seventh #triMSonline conference is now available!
Watch the full programme and visit our booths and posters too!
https://t.co/7Sus7rwTKV
#triMS#BTKinhibitors
Thank you to our Silver sponsor Novartis for supporting the seventh #triMSonline conference.
On-demand content coming on 1 June! https://t.co/7Sus7rwlVn
#triMSonline#BTKinhibitors
That brings us to the end of our seventh #triMSonline conference! Thank you for joining us and we hope you enjoyed it.
Remember that you can revisit the conference content for up to 3 months by logging onto the platform.
#triMS#MS#HCPs
Get ready to join Professor Frauke Zipp's closing lecture exploring the 'Positioning of BTK inhibitors in the MS treatment landscape.'
Don’t forget to also submit your questions for the final Q&A session: https://t.co/YUOUQr4DUe
#triMS#MS#HCPs
Up next in the theatre, 'Learnings from other autoimmune diseases – a safety perspective', presented by Mohammad Sahraian, Professor of Clinical Neurology at Tehran University of Medical Sciences.
#triMS#MS#HCPs
Join Dr Karolina Piasecka-Stryczyńska, Neurological Specialist at Poznań University of Medical Sciences, as she discusses the 'Clinical development of BTK inhibitors in MS – what do we know so far?'
#triMS#MS#HCPs
Coming up next in the theatre, 'Prospects of BTK inhibitors for long-term administration in MS' presented by Kottil Rammohan, Professor of Neurology at the University of Miami.
Don’t forget to submit your questions for the Q&A session: https://t.co/YUOUQr464G
We hope you enjoyed the first half of this #triMSonline conference! What has been your favourite part so far?
Please take the opportunity during the break to explore the exhibit hall and poster hall before presentations resume in the theatre.
#triMSonline#MS#HCPs